VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NERV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NERVMinerva Neurosciences, Inc.
$4.77$33M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNERVQuarterly Financials

Minerva Neurosciences, Inc. (NERV) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Minerva Neurosciences, Inc. (NERV) quarterly income statement — complete revenue, gross profit & net income history

NERV Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21
Sales/Revenue00000000000000000000
Revenue Growth %-------------------100%-
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %-------------------100%-
Operating Expenses16.67M4.98M2.84M3.37M4.52M4.37M6.28M6.68M7.17M6.08M4.52M5.35M5.07M5.21M6.97M7.99M21.38M7.52M8.96M7.51M
OpEx % of Revenue--------------------
Selling, General & Admin11.42B2.81M1.92M2.08M2.54M2.48M2.42M2.51M2.45M2.64M2.63M2.69M1.88M2.84M2.83M3.03M2.63M3M3.44M4.25M
SG&A % of Revenue--------------------
Research & Development5.25B2.17M925.38K1.3M1.98M1.89M3.86M4.17M4.72M3.44M1.89M2.65M3.19M2.37M4.13M4.96M18.75M4.51M5.52M3.26M
R&D % of Revenue--------------------
Other Operating Expenses-1000K0000000000000000000
Operating Income-16.67M-4.98M-2.84M-3.37M-4.52M-4.37M-6.28M-6.68M-7.17M-6.08M-4.52M-5.35M-5.07M-5.21M-6.97M-7.99M-21.38M-7.52M-8.96M-7.51M
Operating Margin %--------------------
Operating Income Growth %--10.16%34.86%46.25%36.95%28.17%-38.88%-24.93%-41.47%-16.75%35.11%33.05%76.28%30.73%22.29%-6.42%-192.86%7.08%-130.38%38.82%
EBITDA-16.67M-4.98M-2.84M-3.37M-4.52M-4.36M-6.27M-6.67M-7.16M-6.07M-4.51M-5.34M-5.06M-5.21M-6.89M-7.99M-21.38M-7.5M-8.92M-7.46M
EBITDA Margin %--------------------
EBITDA Growth %--10.16%34.81%46.21%36.9%28.17%-38.95%-24.97%-41.49%-16.64%34.52%33.12%76.31%30.62%22.74%-6.98%-194.66%6.75%-130.18%38.96%
D&A (Non-Cash Add-back)01.36K1.36K1.36K1.36K5.62K7.75K7.75K7.75K7.75K7.75K7.75K6.38K2.13K00-44414.94K44.01K42.83K
EBIT-16.67M-283.67M-2.74M-3.26M-4.27M22.51M-5.92M-6.32M-6.83M-5.74M-4.16M-4.99M-4.8M-5.02M-6.89M-7.99M-21.38M-7.52M-8.98M-7.51M
Net Interest Income629.6K00136.67K239.72K313.97K-1.95M-2.25M-1.83M-1.74M-1.67M-1.98M-1.37M-1.7M-1.83M-1.78M-1.73M-1.69M-1.61M-1.3M
Interest Income629.6K00136.67K239.72K313.97K360.75K0358.88K348.68K365.62K0556.95K180.09K000000
Interest Expense0000002.31M2.25M2.19M2.08M2.03M1.98M1.93M1.88M1.83M1.78M1.73M1.69M1.61M1.3M
Other Income/Expense-108.73M-278.69M100.39K115.56K250.11K26.88M-1.96M-1.89M-1.85M-1.74M-1.67M-1.62M-1.66M-1.69M-1.75M-1.78M-1.73M-1.69M-1.63M-1.3M
Pretax Income-125.4M-283.67M-2.74M-3.26M-4.27M22.51M-8.23M-8.57M-9.02M-7.82M-6.19M-6.97M-6.73M-6.9M-8.72M-9.76M-23.11M-9.21M-10.59M-8.8M
Pretax Margin %--------------------
Income Tax0000000000000000-1.8M000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%7.8%0%0%0%
Net Income-125.4M-283.67M-2.74M-3.26M-4.27M22.51M-8.23M-8.57M-9.02M-7.82M-6.19M-6.97M-6.73M-6.9M-8.72M-9.76M-21.31M-9.21M-10.59M-8.8M
Net Margin %--------------------
Net Income Growth %--6540.09%-112.19%60.42%52.65%387.88%-32.97%-22.93%-34.14%-13.33%28.97%28.61%68.43%25.04%17.67%-10.9%-190.89%-13.47%-135.86%27.54%
Net Income (Continuing)-125.4M-283.67M-2.74M-3.26M-4.27M22.51M-8.23M-8.57M-9.02M-7.82M-6.19M-6.97M-6.73M-6.9M-8.72M-9.76M-21.31M-9.21M-10.59M-8.8M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-2.86-25.51-0.36-0.43-0.562.97-1.09-1.13-1.19-1.03-1.12-1.31-1.26-1.61-1.62-1.83-3.99-1.72-1.98-1.65
EPS Growth %--4455.36%-112.12%60.55%52.94%388.35%2.68%13.74%5.56%36.02%30.86%28.42%68.42%6.4%18.18%-10.91%-185%-10.97%-133.9%33.47%
EPS (Basic)-2.86-25.51-0.36-0.43-0.562.97-1.09-1.13-1.19-1.03-1.12-1.31-1.26-1.61-1.62-1.83-3.99-1.72-1.98-1.65
Diluted Shares Outstanding43.9M11.12M7.57M7.57M7.57M7.57M7.57M7.57M7.57M7.57M5.51M5.34M5.34M5.34M5.34M5.34M5.34M5.34M5.34M5.34M
Basic Shares Outstanding43.9M11.12M7.57M7.57M7.57M7.57M7.57M7.57M7.57M7.57M5.51M5.34M5.34M5.34M5.34M5.34M5.34M5.34M5.34M5.34M
Dividend Payout Ratio--------------------